mycalamide analogs (Kaken)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namemycalamide analogs (Kaken)
Drug Alias NameN/A
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsVesicular stomatitis virus infectionHerpes Simplex Virus Type 2 InfectionsNeoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKaken Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKaken Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsVesicular stomatitis virus infectionHerpes Simplex Virus Type 2 InfectionsNeoplasms +[4] 

Other Information

ATC CodeN/A
Related LinksN/A